Alexandra Y. Rak

12 Acad. Pavlov Street
Saint Petersburg, SPE 197022, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

The Shifting Core: Antigenic Variability of the Influenza Virus Nucleoprotein Despite Evolutionary Conservation.

The Shifting Core: Antigenic Variability of the Influenza Virus Nucleoprotein Despite Evolutionary Conservation.

Journal: Antibodies (Basel, Switzerland)

Published: March 20, 2026

Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties.

Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties.

Journal: Antibodies (Basel, Switzerland)

Published: November 14, 2025

Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid Protein.

Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid Protein.

Journal: Antibodies (Basel, Switzerland)

Published: April 19, 2025

Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters.

Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters.

Journal: Vaccines

Published: October 31, 2024

Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates.

Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates.

Journal: Vaccines

Published: August 19, 2024

A novel immunofluorescent test system for SARS-CoV-2 detection in infected cells.

A novel immunofluorescent test system for SARS-CoV-2 detection in infected cells.

Journal: PloS one

Published: February 26, 2024

Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.

Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.

Journal: Virology journal

Published: January 09, 2024

Overview of Nucleocapsid-Targeting Vaccines against COVID-19.

Overview of Nucleocapsid-Targeting Vaccines against COVID-19.

Journal: Vaccines

Published: November 04, 2023

Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines.

Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines.

Journal: Vaccines

Published: October 08, 2023

RDE Treatment Prevents Non-Specific Detection of SARS-CoV-2- and Influenza-Specific IgG Antibodies in Heat-Inactivated Serum Samples.

RDE Treatment Prevents Non-Specific Detection of SARS-CoV-2- and Influenza-Specific IgG Antibodies in Heat-Inactivated Serum Samples.

Journal: Antibodies (Basel, Switzerland)

Published: May 01, 2023

Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model.

Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model.

Journal: Viruses

Published: January 04, 2023

Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein.

Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein.

Journal: Vaccines

Published: December 03, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026